Harrison M R, Adzick N S, Bullard K M, Farrell J A, Howell L J, Rosen M A, Sola A, Goldberg J D, Filly R A
Fetal Treatment Center and the Department of Surgery, University of California, San Francisco, 94143-0570, USA.
J Pediatr Surg. 1997 Nov;32(11):1637-42. doi: 10.1016/s0022-3468(97)90472-3.
Congenital diaphragmatic hernia (CDH) remains an unsolved problem. Despite optimal postnatal care, up to 60% of CDH babies die. Experimental evidence and clinical experience have shown that in utero repair of CDH is feasible and can reverse pulmonary hypoplasia, but only in fetuses without liver herniation. For this subgroup, the safety and efficacy of repair before birth has not been compared with standard care after birth.
Four fetuses in whom CDH without liver herniation was diagnosed underwent open fetal surgery for repair of the CDH. Seven comparison fetuses were treated conventionally. Neonatal mortality was the principle outcome variable. Secondary outcome variables included death of all causes until 2 years of age, number of days of ventilatory support, length of hospital stay, requirement for extracorporeal membrane oxygenation (ECMO), and total hospital charges.
There was no difference in survival between the fetal surgery group and the postnatally treated comparison group (75% v 86%). Fetal surgery patients were born more prematurely than the comparison group (32 weeks v 38 weeks' gestation). Length of ventilatory support and requirement for ECMO were equivalent in the fetal surgery group and the postnatally treated comparison group. Length of hospital stay and hospital charges did not differ between the groups.
Open fetal surgery is physiologically sound and technically feasible, but does not improve survival over standard postnatal treatment in the subgroup of CDH fetuses without liver herniation, primarily because overall survival in this subgroup is favorable with or without prenatal intervention. These data suggest that fetuses who have prenatally diagnosed CDH and without evidence of liver herniation should be treated postnatally.
先天性膈疝(CDH)仍是一个尚未解决的问题。尽管产后给予了最佳护理,但仍有高达60%的CDH患儿死亡。实验证据和临床经验表明,子宫内修复CDH是可行的,并且可以逆转肺发育不全,但仅适用于无肝脏疝入的胎儿。对于这一亚组,出生前修复的安全性和有效性尚未与出生后的标准护理进行比较。
4例诊断为无肝脏疝入的CDH胎儿接受了开放性胎儿手术以修复CDH。7例对照胎儿接受常规治疗。新生儿死亡率是主要的结局变量。次要结局变量包括2岁前各种原因导致的死亡、通气支持天数、住院时间、体外膜肺氧合(ECMO)需求以及总住院费用。
胎儿手术组和出生后治疗的对照组在生存率上无差异(75%对86%)。胎儿手术组患儿的出生孕周比对照组更早(32周对38周妊娠)。胎儿手术组和出生后治疗的对照组在通气支持时间和ECMO需求方面相当。两组之间的住院时间和住院费用没有差异。
开放性胎儿手术在生理上合理且技术上可行,但对于无肝脏疝入的CDH胎儿亚组,与标准产后治疗相比并不能提高生存率,主要是因为无论有无产前干预,该亚组的总体生存率都较好。这些数据表明,产前诊断为CDH且无肝脏疝入证据的胎儿应在出生后进行治疗。